Related Experiment Videos
Cryotherapy for retinopathy of prematurity in a regional neonatal intensive care unit
Insights
Cryotherapy effectively treated retinopathy of prematurity (ROP) in premature infants, with most cases regressing. However, some infants experienced disease progression or complications, necessitating careful monitoring.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Early detection and treatment are crucial for preventing severe visual outcomes.
- Cryotherapy is a recognized treatment modality for ROP.
Purpose of the Study:
- To evaluate the efficacy of cryotherapy in treating 'treatable' retinopathy of prematurity.
- To assess the response and identify complications associated with cryotherapy in premature infants.
- To analyze outcomes in infants treated for ROP over a 3-24 month follow-up period.
Main Methods:
- Prospective evaluation of 30 eyes from 15 low birth-weight premature infants diagnosed with treatable ROP.
- Screening of 96 infants at risk for ROP over a 25-month period.
- Monitoring of treatment response and complications following cryotherapy.
Main Results:
- Regression of active ROP was observed in 24 eyes (12 infants) post-cryotherapy.
- Six eyes (3 infants) progressed to cicatricial disease despite treatment.
- One infant developed angle closure glaucoma; no cicatricial disease was noted in those eyes.
Conclusions:
- Cryotherapy demonstrated efficacy in achieving regression of active retinopathy of prematurity in a majority of treated infants.
- Potential complications, including disease progression and glaucoma, were observed, highlighting the need for vigilant follow-up.
- The study discusses local and systemic complications associated with cryotherapy for ROP.
Abstract:
Ninety-six low birth-weight premature infants at risk of retinopathy of prematurity (ROP) were screened over a 25-month period, yielding 30 eyes of 15 infants with 'treatable' disease. The response and complications of cryotherapy were prospectively evaluated in these infants over a 3-24-month period. Six eyes of three infants progressed to cicatricial disease despite treatment. One infant developed angle closure glaucoma but neither eye showed cicatricial disease. In 24 eyes of 12 infants regression of active ROP was observed after treatment. The local and systemic complications associated with cryotherapy are discussed.